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A generalized skin erythema and severe hypotension developed following administration of protamine for the reversal of
heparin anticoagulation after an unsuccessful attempt at percutaneous transluminal angioplasty in a patient who had never
been exposed to protamines before. Evidence of classical pathway complement activation was present indicating that this
reaction could have been triggered by a non-immunological mechanism. The patient could not adequately be resuscitated
because of the presence of severe coronary artery disease.
Introduction
The widespread use of protamine for the reversal of
heparin anticoagulation has attracted great attention
because of its potentially harmful side effects. However,
most of the adverse reactions are reported in patients
undergoing heparin neutralization after cardiopulmon-
ary bypass or in patients previously exposed to pro-
tamines. Here we report a case of fatal protamine reaction
in a patient with no history of prior protamine exposure
who underwent an unsuccessful attempt of percutaneous
transluminal coronary angioplasty.
Case report
A 64-year-old man was admitted for unstable angina.
He had never had surgery before, had no known allergies
and had none of the previously reported risk factors attri-
buted to protamine allergy, such as the use of protamine-
containing NPH insulins, a prior vasectomy or a history
offish allergy1'21. The electrocardiogram showed normal
sinus rhythm and flattening of the ST segment in V^ . The
stress test performed the evening before catheterization
was clinically and electrically positive at 100 W with an ST
segment depression of more than 1-5 mm in II, III and
aVF and ST segment elevation in V,^ lasting for more
than lOmin.
The coronary angiography showed a proximal total
occlusion of the left anterior descending coronary artery,
its distal bed being collateralized by the dominant right
coronary artery. The right coronary artery showed several
significant stenoses. A localized hypokinesia of the
anterior wall was present, with normal global ventricular
function. At the end of the diagnostic study, it was decided
to attempt recanalization of the occluded left anterior
descending coronary artery, by percutaneous translumi-
nal coronary angioplasty. For anticoagulation 20 000
units of heparin (LiquemineR, Hoffmann-LaRoche,
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Basel, Switzerland) and 250 mg of aspirin were adminis-
tered intravenously. The occluded left anterior descend-
ing coronary artery could not be passed and elective
bypass surgery was recommended to the patient. He had
been asymptomatic during the entire intervention.
Before removal of the catheter placed in the femoral
artery, i.e. about 45 min after anticoagulation, heparin
was reversed with 200 mg protamine hydrochlorid (Pro-
tamine 1000, Hoffmann-La Roche, Basel, Switzerland) as
an intravenous bolus. Approximately 2 min later, the
patient developed a generalized skin erythema, became
restless and complained about general itching, but
without evidence of bronchospasm. The arterial blood
pressure (120/80 mmHg) and heart rate (84-94 beat
min~') remained unchanged. Diphenhydramine (50 mg),
a histamine-receptor-blocking agent, and prednisone
(100 mg) were given intravenously. However, 10 min
later, systolic blood pressure dropped (< 70 mmHg). A
crystalloid solution was rapidly administered together
with 10mg of adrenaline subcutaneously, without any
effect on blood pressure. Therefore a second dose of
1-0 mg of adrenaline was infused slowly into a peripheral
vein. Systolic blood pressure transiently increased
(>90 mmHg) but the patient complained about typical
chest pain. An ST elevation of more than 1-5 mm was
observed in the infero-lateral leads, and the systolic blood
pressure dropped progressively (< 50 mmHg). Cardio-
pulmonary resuscitation was started, the patient was
intubated and ventilated with 100% oxygen. Peak airway
pressure was above 35 cmH20, indicating the occurrence
of bronchospasm and/or acute pulmonary oedema.
Several episodes of ventricular fibrillation occurred
necessitating defibrillation. However, although adequate
blood pressure could be maintained initially by cardiac
massage and intravenous administration of inotropes,
irreversible electro-mechanical dissociation developed,
and the patient could not be resuscitated.
To corroborate the diagnosis of protamine-induced
adverse reaction, different components of the comp-
lement system were determined in plasma, left from
the blood sample routinely taken before percutaneous
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Table 1 Total haemolylic complement (CHX) and the complement
components C3 and C4 before and after adverse protamine reaction















Figure 1 Two-dimensioned immunoelectrophoresis showing acti-
vation of C3. Without activation, no C3b is visible.
transluminal angioplasty, and from a blood sample taken
during cardiopulmonary resuscitation.
The results of complement fragments are given in
Table 1 and Fig. 1. Histamine could be measured only in
the first blood sample and was, with 23-7 nmol I"1, well
above the normal value of less than 10 nmol 1 ~'.
At autopsy, there was a haemopericardium containing
400 ml of fresh blood associated with a perforation of
the right ventricle measuring 0-3 cm in diameter (most
probably due to the temporary pacemaker during resusci-
tation). The hypertrophic heart (535 g) showed extensive
arteriosclerosis with an occlusion of the left anterior des-
cending coronary artery, 1-8 cm after its origin and a
stenosis, occluded by a fresh thrombus, in the right
coronary artery, 5 cm distally of its ostium. A recent
antero-septal and postero-lateral infarct was present. The
aortic valve showed signs of inactive endocarditis with
multiple perforations of the leaflets. Both lungs showed
congestion and oedema. The thoraco-abdominal aorta
and its branches showed severe arteriosclerosis.
Discussion
The patient probably died from acute occlusion of the
right coronary artery supplying blood to the inferior
and, via collaterals, to the anterior myocardial wall.
This occlusion was triggered by the adverse reaction to
protamine.
It appears that protamine can induce more than
one type of adverse response in humans. Complement
activation through the classical pathway, timely related
to protamine administration, can occur after cardiac
catheterization in patients with previous exposure to
protamine12'. The depletion of haemolytic complement
activity, C4 and C3 and the presence of circulating C3b
suggests that the classical complement pathway was acti-
vated in our patient despite no history of prior exposure
to protamine. This indicates that complement was most
probably not activated by an immune complex131 but
rather by an interaction between the polycation pro-
tamine and the polyanion heparin'4-51. C-reactive protein
which is increased during myocardial ischaemia, enhances
this reaction161. Split products of complement activation
such as C3a and C5a or complement-induced release of
histamine has been proposed as being one of the causes
of protamine-induced hypotension178'. However, we
cannot exclude that a non-specific, non-immunological
protamine-induced release of cellular mediators, e.g.
histamine, caused the severe hypotension. As in another
case reported'81, our patient had an increased plasma
histamine level prior to protamine exposure, which
suggests that elevated circulating histamine concen-
trations could favour adverse reactions to protamine.
Some patients may poorly tolerate protamine-induced
haemodynamic changes. Slow administration through a
free-running intravenous catheter1'1 may reduce rapid
release of vasoactive substances and allow spontaneous
compensatory mechanisms to become operative. If
protamine is suspected to have caused adverse side
effects it calls for immediate therapeutic intervention.
This includes cessation of protamine administration and
restoration of blood pressure with intravenous fluids, and
cardio-circulatory support drugs. Maintenance of pul-
monary gaseous exchange with supplemental oxygen and,
if necessary, with assisted ventilation is mandatory. As in
our patient, this aggressive therapy may interfere with an
adequate myocardial oxygen supply-demand ratio'10',
leading to ventricular arrythmia, fibrillation and
eventually electro-mechanical dissociation.
Cardiac catheterization can be safely performed
without the use of protamine. We therefore advocate that
it should be administered only if it can significantly con-
tribute to reduce bleeding in a heparinized patient. The
occlusion of the right coronary artery by a fresh thrombus
in our patient may have been favoured by the reversal of
heparin activity, combined with low blood flow due to
systemic hypotension.
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